Chinese english Germany Japanese Korea

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)-

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)- Struktur
917389-29-8
CAS-Nr.
917389-29-8
Englisch Name:
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)-
Synonyma:
LeterMovir-004;Letomovir impurity A;Letimovir Impurity ZY1;DDWYVVLPVLTZIN-DEOSSOPVSA-N;METHANAMINE,N,N,1-TRIFLUORO-;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)-
CBNumber:
CB83137952
Summenformel:
C30H30F4N4O4
Molgewicht:
586.58
MOL-Datei:
917389-29-8.mol
Request For Quotation

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)- Eigenschaften

Siedepunkt:
662.2±65.0 °C(Predicted)
Dichte
1.33±0.1 g/cm3(Predicted)
pka
4.85±0.20(Predicted)

Sicherheit

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)- Chemische Eigenschaften,Einsatz,Produktion Methoden

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 16)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shijiazhuang yaoBo Pharmaceutical Co., Ltd. 15633056635
 2880679888@qq.com China 2872 58
Shanghai Yu Ben Biotechnology Co., Ltd. 15502154572
 yuben012@sina.com China 507 58
Jinan Guoding Pharmaceutical Technology Co., Ltd. 15665775653
 sales@guodingpharma.com China 483 58
Shandong Chengchuang Blue Sea Pharmaceutical Technology Co., Ltd. 0531-58897130 15508676053
 drug_impurity@sdcclh.com China 1932 58
Guangzhou Jiuzhi Pharmaceutical Technology Co., Ltd. 020-89854820
sales@jzpharma.cn China 1081 58
Nanjing wangzhixing Pharmaceutical Technology Co., Ltd 15850510341
 shiqingran@wzxchem.com China 3639 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
 2853117764@qq.com China 7743 58
QUALITY CONTROL SOLUTIONS LTD. 13670046396
 ORDERS@QCSRM.COM China 18899 58
Shenzhen Roark Pharma-Tec Co., Ltd. 13128912434
 2880126944@qq.com China 2579 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
 czbjpharma@126.com China 18488 58
  • 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, methyl ester, (4S)-
  • DDWYVVLPVLTZIN-DEOSSOPVSA-N
  • LeterMovir-004
  • Letomovir impurity A
  • Letimovir Impurity ZY1
  • METHANAMINE,N,N,1-TRIFLUORO-
  • 917389-29-8
Copyright 2019 © ChemicalBook. All rights reserved